secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001438133-24-000118
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes stockholders approve 3M-share increases to ESPP and LTIP at annual meeting
--------------------------------------------------------------------------------

- Stockholders elected all 9 director nominees; highest vote count for John Sheridan (50.3M for).
- Approved amendment to 2013 ESPP to increase authorized shares by 3,000,000; 50.4M for, 117,501 against.
- Approved amendment to 2023 LTIP to increase authorized shares by 3,000,000; 47.6M for, 3.0M against.
- Advisory say-on-pay approved: 47.9M for, 2.3M against, 299,108 abstain.
- Ratified Ernst & Young as independent auditor for FY 2024: 53.2M for, 1.4M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000118/0001438133-24-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000118/tndm-20240522.htm
  HTML page:      https://secwatch.observer/filing/0001438133-24-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer